Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 1.36B P/E - EPS this Y 16.10% Ern Qtrly Grth -
Income -198.13M Forward P/E -8.20 EPS next Y 10.40% 50D Avg Chg -5.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg -11.00%
Dividend N/A Price/Book 4.51 EPS next 5Y - 52W High Chg -35.00%
Recommedations 2.00 Quick Ratio 2.16 Shares Outstanding 120.03M 52W Low Chg 27.00%
Insider Own 25.00% ROA -43.15% Shares Float 51.32M Beta -
Inst Own 57.76% ROE -88.19% Shares Shorted/Prior 10.21M/9.67M Price 14.03
Gross Margin - Profit Margin - Avg. Volume 406,400 Target Price 15.67
Oper. Margin - Earnings Date - Volume 317,036 Change -5.46%
About Prime Medicine, Inc.

Prime Medicine, Inc., a biotechnology company, delivers genetic therapies to address the spectrum of diseases by deploying gene editing technology. The company offers Prime Editors with a Prime Editor protein, comprising a fusion between a Cas protein and a reverse transcriptase enzyme; and a pegRNA, which targets the Prime Editor to a specific genomic location and provides a template for making the desired edit to the target DNA sequence. It has a research collaboration with Cimeio Therapeutics to develop Prime Edited Shielded-Cell & Immunotherapy Pairs for genetic diseases, acute myeloid leukemia, and myelodysplastic syndrome. The company was incorporated in 2019 and is based in Cambridge, Massachusetts.

Prime Medicine, Inc. News
05/01/24 Prime Medicine to Participate in the 27th Annual Milken Institute Global Conference
04/30/24 Prime Medicine gets green light for trials of first-ever prime editing drug
04/29/24 Prime gets FDA green light to begin first trial test of ‘prime editing’
04/29/24 Prime Medicine Announces FDA Clearance of Investigational New Drug (IND) Application for PM359 for the Treatment of Chronic Granulomatous Disease (CGD)
04/23/24 Prime Medicine to Present Preclinical Data Demonstrating Broad Potential of Prime Editing Technology at Upcoming Scientific Meetings
03/27/24 2 Magnificent Growth Stocks With Room to Run
03/14/24 Short-Squeeze Roulette: 3 Stocks That Could Leave Bears Begging
03/01/24 Cathie Wood Just Bought These 3 Biotech Stocks. Should You Buy, Too?
03/01/24 Prime Medicine Reports Full Year 2023 Financial Results and Provides Business Updates
02/29/24 14 Stocks With Heavy Insider Buying In 2024
02/28/24 Prime Medicine to Participate in Upcoming Investor Conferences
02/25/24 With 34% ownership, Prime Medicine, Inc. (NASDAQ:PRME) has piqued the interest of institutional investors
02/20/24 Prime Medicine Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
02/14/24 Prime Medicine Announces Pricing of Upsized Public Offering
02/14/24 Prime Medicine Announces Proposed Public Offering of Common Stock
02/01/24 Prime Medicine to Present at Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
01/25/24 Prime Medicine Receives Up to $15 Million from Cystic Fibrosis Foundation to Advance Hotspot and PASSIGE™ Prime Editors for Cystic Fibrosis
01/09/24 Wall Street Analysts Predict an 111.38% Upside in Prime Medicine, Inc. (PRME): Here's What You Should Know
01/05/24 Prime Medicine Appoints Allan Reine, M.D., as Chief Financial Officer
08:00 AM Prime Medicine to Present at 42nd Annual J.P. Morgan Healthcare Conference
PRME Chatroom

User Image Sandpiper22 Posted - 8 hours ago

$PRME say goodbye to sub $5

User Image Oversold_Gems Posted - 11 hours ago

$PRME

User Image Oversold_Gems Posted - 11 hours ago

$PRME

User Image Stock_Titan Posted - 18 hours ago

$PRME Prime Medicine to Participate in the 27th Annual Milken Institute Global Conference https://www.stocktitan.net/news/PRME/prime-medicine-to-participate-in-the-27th-annual-milken-institute-v04gdfr2bw5i.html

User Image piku99 Posted - 04/30/24

$PRME fanfare of $20 to below 4, slowly and steadily!!

User Image Etrading Posted - 04/29/24

$SPY $prme that will bring some hype and push to prme that why i bought back today... https://investors.primemedicine.com/news-releases/news-release-details/prime-medicine-announces-fda-clearance-investigational-new-drug $sofi $tsla $dna

User Image Sandpiper22 Posted - 04/29/24

$CRBU XBI and small caps roaring...have a day $PRME congrats on the IND clearance.

User Image Etrading Posted - 04/29/24

$PRME today news is good and no volume yet here i loaded and will wait for RUN ... $spy $sofi $tsla $arkk

User Image Etrading Posted - 04/29/24

Not sure what i must be more excited about? for my $tsla call? or huge $rxrx share from dips? or $sofi took profit while people in big fomo; or added back some $prme at today pulls or $amzn call (that is nothing now)

User Image Etrading Posted - 04/29/24

$rxrx $8.40 is the key for breakout .. but I am not in hurry since I want to add more !! $prme got back on this one too after today good news $sofi $tsla

User Image briefingcom Posted - 04/29/24

$PRME: Prime Medicine announced that the FDA has cleared the company’s Investigational New Drug (IND) application for PM359 https://www.briefing.com/in-depth-analysis/content/article?ArticleId=IN20240429070513PRME&utm_campaign=inplay&utm_medium=social&utm_source=st&utm_content=view_page

User Image BigSqueezeComing Posted - 04/29/24

$PRME here it comes

User Image BigSqueezeComing Posted - 04/29/24

$PRME vol???

User Image BigSqueezeComing Posted - 04/29/24

$PRME https://finance.yahoo.com/news/prime-medicine-announces-fda-clearance-110000440.html

User Image DonCorleone77 Posted - 04/29/24

$PRME Prime Medicine announces FDA clearance of IND application for PM359 Prime Medicine announced that the U.S. Food and Drug Administration, FDA, has cleared the company's Investigational New Drug, IND, application for PM359, submitted on March 29, for the treatment of chronic granulomatous disease, CGD, enabling the Company to initiate its global Phase 1/2 clinical trial in the United States. "We are thrilled to achieve this important milestone for our first product candidate, PM359, which represents the first-ever IND clearance for a Prime Editor product candidate and a significant advancement in the field of next-generation gene editing," said Keith Gottesdiener, M.D., President and Chief Executive Officer of Prime Medicine. "Based on data from our preclinical studies, we believe PM359 has the potential to sufficiently correct a prevalent disease-causing mutation of CGD, leading to amelioration of disease for these patients. We look forward to the planned initiation of our Phase 1/2 trial and further determining the potential therapeutic impact of PM359 in patients with this devastating disease."

User Image Stock_Titan Posted - 04/29/24

$PRME Prime Medicine Announces FDA Clearance of Investigational New Drug (IND) Application for PM359 for the Treatment of Chronic Granulomatous Disease (CGD) https://www.stocktitan.net/news/PRME/prime-medicine-announces-fda-clearance-of-investigational-new-drug-9xlmejd9obu0.html

User Image Oversold_Gems Posted - 04/28/24

$PRME

User Image Sandpiper22 Posted - 04/27/24

$PRME flipping under $5 is fun…won’t last long though 📈

User Image ScottyBillz Posted - 04/26/24

$PRME longg

User Image Etrading Posted - 04/26/24

$roku and $intc soon buy the dips will be; not yet.. meanwhile adding more $sofi $rxrx at this dips even $prme stupidly low

User Image Etrading Posted - 04/25/24

$PRME MC only 500M and too many upgrade recently !! i ll add some for quick swing for a few days hold... my $meta 400-410 add alert worked well for quick swing $tsla too strong... BUY THE RUMOR 8/8/2024 ROBOTAXI-AI etc pump $spy

User Image MagisterofMarkets Posted - 04/25/24

$PRME $CRBU $VERV $BEAM $NTLA cant stop buying, I guess I’m a sucker for pain

User Image Sandpiper22 Posted - 04/24/24

$PRME buying more tomorrow.

User Image Etrading Posted - 04/24/24

$rxrx and $prme and $sofi giving nice dips at open to buy back $TSLA option burn at open !!!

User Image Etrading Posted - 04/23/24

Bears 🐻 will be scare after $NVDA earning for $RXRX !! This will be way better than $TSLA .. Plus $prme .. Thank me later like last time rxrx 14-15 pump $SPY

User Image Sandpiper22 Posted - 04/23/24

$PRME just your casual AH purchase of 99,973 shares @ $5.00 (time stamp of 5:38 pm ET)

User Image Etrading Posted - 04/23/24

$prme stupid seller selling my prme and $rxrx just like they did my $sofi yesterday at 7.10 but those bears quite at sofi now... screw your games- i buy more even over buy at every pulls-- instead OVERBNOUGHT MAG7 i buy these. $spy $tsla

User Image Etrading Posted - 04/23/24

Wedbush Reiterates Outperform on Prime Medicine, Maintains $12 Price Target $PRME I sold this recently but i am buying back and this time planning to hold longer $spy $tsla

User Image briefingcom Posted - 04/23/24

$PRME: Prime Medicine to present preclinical data demonstrating broad potential of prime editing technology at upcoming scientific meetings https://www.briefing.com/in-depth-analysis/content/article?ArticleId=IN20240423080731PRME&utm_campaign=inplay&utm_medium=social&utm_source=st&utm_content=view_page

User Image Sandpiper22 Posted - 04/23/24

$CRBU $PRME $PSTX penny flip at your own peril

Analyst Ratings
Wedbush Outperform Apr 23, 24
Chardan Capital Buy Apr 22, 24
TD Cowen Buy Apr 8, 24
Wedbush Outperform Apr 3, 24
Wedbush Outperform Apr 2, 24
Guggenheim Buy Mar 5, 24
Citigroup Neutral Dec 8, 23
JP Morgan Overweight Nov 7, 23
BMO Capital Outperform Oct 9, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
GV 2019 GP, L.L.C. 10% Owner 10% Owner Jun 20 Sell 15.01 56,408 846,684 06/22/23
GV 2019 GP, L.L.C. 10% Owner 10% Owner Jun 09 Sell 14.73 31,703 466,985 06/13/23
GV 2019 GP, L.L.C. 10% Owner 10% Owner May 22 Sell 14.43 131,861 1,902,754 05/24/23
GV 2019 GP, L.L.C. 10% Owner 10% Owner Oct 24 Buy 17 800,000 13,600,000 11,522,248 10/26/22